Published in Annu Rev Pharmacol Toxicol on September 19, 2011
Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | NCT03633630
Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS (2012) 1.55
Evaluating user perceptions of mobile medication management applications with older adults: a usability study. JMIR Mhealth Uhealth (2014) 1.54
Improving adherence with medication: a selective literature review based on the example of hypertension treatment. Dtsch Arztebl Int (2014) 1.22
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin Pharmacol Ther (2012) 1.08
Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis (2013) 1.08
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project. J Int AIDS Soc (2017) 1.06
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr (2014) 1.00
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention. AIDS Res Hum Retroviruses (2013) 0.98
Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS (2015) 0.96
Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges. Haematologica (2014) 0.96
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag (2013) 0.94
Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa. AIDS Behav (2013) 0.91
Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. J Pharm Biomed Anal (2016) 0.90
A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol (2016) 0.87
Predictive patterns of early medication adherence in renal transplantation. Transplantation (2014) 0.87
Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol (2013) 0.87
Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies. CPT Pharmacometrics Syst Pharmacol (2013) 0.85
The development of the ProMAS: a Probabilistic Medication Adherence Scale. Patient Prefer Adherence (2015) 0.84
The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.84
Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. AIDS Behav (2013) 0.83
Long acting systemic HIV pre-exposure prophylaxis: an examination of the field. Drug Deliv Transl Res (2017) 0.82
Antihypertensive drug class and adherence: an electronic monitoring study. Am J Hypertens (2014) 0.82
Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies. J Clin Pharmacol (2013) 0.82
Nurse-led interventions to enhance adherence to chronic medication: systematic review and meta-analysis of randomised controlled trials. Eur J Clin Pharmacol (2012) 0.82
Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci (2017) 0.82
Model-based clinical drug development in the past, present and future: a commentary. Br J Clin Pharmacol (2015) 0.81
Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans. J Clin Pharmacol (2015) 0.81
Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects. AAPS PharmSciTech (2015) 0.81
Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm (2015) 0.80
Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2013) 0.79
Time-in-a-bottle (TIAB): a longitudinal, correlational study of patterns, potential predictors, and outcomes of immunosuppressive medication adherence in adult kidney transplant recipients. Clin Transplant (2013) 0.78
PrEP Adherence Patterns Strongly Affect Individual HIV Risk and Observed Efficacy in Randomized Clinical Trials. J Acquir Immune Defic Syndr (2016) 0.78
Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder. Drug Alcohol Depend (2016) 0.77
Mitigating the Effects of Nonadherence in Clinical Trials. J Clin Pharmacol (2016) 0.77
The meaning of adherence when behavioral risk patterns vary: obscured use- and method-effectiveness in HIV-prevention trials. PLoS One (2012) 0.77
Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). Br J Clin Pharmacol (2014) 0.77
Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa. PLoS One (2016) 0.76
Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. J Hum Hypertens (2015) 0.76
Desirability and feasibility of wireless electronic monitoring of medications in clinical trials. Transl Behav Med (2015) 0.76
Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. Int Clin Psychopharmacol (2012) 0.76
The effect of placebo adherence on reducing cardiovascular mortality: a meta-analysis. Clin Res Cardiol (2013) 0.75
Current Situation of Medication Adherence in Hypertension. Front Pharmacol (2017) 0.75
A systematic review of medication exposure assessment in prospective cohort studies of community dwelling older australians. PLoS One (2015) 0.75
Effectiveness of a medication-adherence tool: study protocol for a randomized controlled trial. Trials (2016) 0.75
Quantification of the Forgiveness of Drugs to Imperfect Adherence. CPT Pharmacometrics Syst Pharmacol (2015) 0.75
Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment. J Pharmacokinet Pharmacodyn (2015) 0.75
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials. J Clin Psychopharmacol (2016) 0.75
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia. JMIR Mhealth Uhealth (2017) 0.75
Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders. J Clin Psychopharmacol (2016) 0.75
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc (2017) 0.75
An examination of 1-year adherence and persistence rates to antiepileptic medication in children with newly diagnosed epilepsy. J Pediatr Psychol (2014) 0.75
Medication safety through e-health technology: can we close the gaps? Br J Clin Pharmacol (2013) 0.75
HIV treatment as prevention in men who have sex with men: examining the evidence. CMAJ (2015) 0.75
A prospective test of the late effects of potentially antineuroplastic drugs in a stroke rehabilitation study. Int J Stroke (2012) 0.75
Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial. Biomarkers (2016) 0.75
Personalized Drug Dosage - Closing the Loop. Pharm Res (2016) 0.75
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment. Open Forum Infect Dis (2017) 0.75
Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation. PLoS One (2017) 0.75
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ (2008) 3.24
Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension (2013) 2.32
Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. J Rheumatol (2003) 1.65
Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail (2003) 1.50
Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. J Clin Pharmacol (2005) 1.50
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol (2007) 1.46
Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab (2007) 1.43
Changes in prescribed drug doses after market introduction. Pharmacoepidemiol Drug Saf (2002) 1.24
Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother (2005) 1.17
Modelling the association between adherence and viral load in HIV-infected patients. Stat Med (2005) 1.16
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation (2013) 1.16
From monitoring to vigilance about patient adherence to new oral anticoagulants. Europace (2013) 1.09
How Islam changed medicine: Ibn Sina (Avicenna) saw medicine and surgery as one. BMJ (2006) 1.02
Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. J Pharmacokinet Pharmacodyn (2007) 0.98
Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges. Haematologica (2014) 0.96
The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. J Acquir Immune Defic Syndr (2010) 0.95
A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments. Biostatistics (2010) 0.95
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial. Antimicrob Agents Chemother (2013) 0.92
Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. J Bone Miner Res (2011) 0.92
Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol (2014) 0.88
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens (2009) 0.88
The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses. Basic Clin Pharmacol Toxicol (2005) 0.87
Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malar J (2010) 0.87
Pharmionics: research on what patients do with prescription drugs. Pharmacoepidemiol Drug Saf (2004) 0.86
Levels of self-reported depression and anxiety among HIV-positive patients in Albania: a cross-sectional study. Croat Med J (2011) 0.86
Comparison of treadmill scores with physician estimates of diagnosis and prognosis in patients with coronary artery disease. Am Heart J (2002) 0.85
Barriers to care and current medical and social needs of HIV-positive patients in Albania. Cent Eur J Public Health (2011) 0.84
Strategies to predict, measure, and improve psychosocial treatment adherence. Harv Rev Psychiatry (2014) 0.79
'Hedged' prescribing for partially compliant patients. Clin Pharmacokinet (2006) 0.78
Revolutionizing volunteer interpreter services: an evaluation of an innovative medical interpreter education program. J Gen Intern Med (2013) 0.78
Some key points emerging from the COX-2 controversy. Pharmacoepidemiol Drug Saf (2005) 0.78
Analysis and interpretation of 24-h blood pressure profiles: appropriate mathematical models may yield deeper understanding. Am J Hypertens (2008) 0.78
Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). Br J Clin Pharmacol (2014) 0.77
Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen. Clin Trials (2009) 0.77
Strategies to Predict, Measure, and Improve Psychosocial Treatment Adherence. Harv Rev Psychiatry (2013) 0.77
The Indian Polycap Study (TIPS). Lancet (2009) 0.76
Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. Int Clin Psychopharmacol (2012) 0.76
Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria. Wien Klin Wochenschr (2015) 0.76
The drugs not taken. Science (2008) 0.75
Response to maximizing treatment adherence: physician–patient partnerships vs procedures. Hypertension (2014) 0.75
Missed opportunities for patient education and social worker consultation at The Arbor Free Clinic. J Health Care Poor Underserved (2004) 0.75
[Compliance, concordance, adherence]. Ther Umsch (2010) 0.75
Antiretroviral therapy adherence and predictors to adherence in Albania: a cross-sectional study. J Infect Dev Ctries (2014) 0.75